Rising cost of state's drug habit
After the controversy over funding the cancer drug Ippy, the government is likely to come under pressure to pay for even more expensive treatments, writes Susan Mitchell.
Anew drug to treat cystic fibrosis has recently been approved for use in the United States. Ivacaftor has been dubbed a wonder drug; officials from the US Federal Drugs Administration (FDA) hailed it as the first drug that targets an underlying cause of CF, rather than treating the symptoms of the disease.
It works by improving hydration of the airways, as well as the functioning of the lungs, and in clinical trials resulted in "significant...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine